Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 5,079 $ 4,828
Accounts receivable 5,529 5,032
Other current assets 2,367 2,294
Total current assets 12,975 12,154
Property and equipment, net 606 480
Intangible assets, net 226 861
Operating lease right of use assets 2,090 2,439
Other long-term assets 45 45
Total assets 15,942 15,979
Current liabilities:    
Accounts payable 1,689 1,050
Accrued salary and bonus 1,127 1,456
Other accrued expenses 8,391 8,419
Line of credit - current 1,500 2,500
Current liabilities of discontinued operations 858 858
Total current liabilities 13,565 14,283
Contingent consideration 231 518
Operating lease liabilities, net of current portion 1,646 1,848
Note payable at fair value 11,307 11,165
Other long-term liabilities 4,863 4,701
Total liabilities 31,612 32,515
Commitments and contingencies (Note 9)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series B issued and outstanding 46,536 46,536
Common stock, $.01 par value; 100,000,000 shares authorized; 4,390,826 and 4,367,830 shares issued, respectively; 4,311,414 and 4,296,710 shares outstanding, respectively 405 405
Additional paid-in capital 187,865 187,516
Accumulated deficit (248,491) (249,017)
Treasury stock, at cost (79,412 and 71,120 shares, respectively) (1,985) (1,976)
Total stockholders’ deficit (62,206) (63,072)
Total liabilities and stockholders’ deficit (30,594) (30,557)
Total liabilities, preferred stock and stockholders’ deficit $ 15,942 $ 15,979